News

Expression Pathology Appoints New President and CEO

Published: February 2, 2012

News

Expression Pathology Appoints New President and CEO

Published: February 2, 2012

Read time:

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Expression Pathology Appoints New President and CEO"

First Name*

Last Name*

Email Address*

Country*

Company Type*

Job Function*

Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Expression Pathology Inc. has announced that Dr. Jon Burrows has been appointed President and Chief Executive Officer.

Dr. Burrows has served as Expression Pathology’s Head of R&D and Executive Vice President since 2009.

He has been instrumental in the development of the company’s technology platform and strategic direction.

Dr. Burrows brings extensive experience in development of clinical tissue assays and a deep understanding of cancer pathways and drug development.

Prior to joining Expression Pathology he held management roles at Ventana Medical Systems (a member of the Roche group) in business development and R&D with responsibilities for managing companion diagnostic development collaborations with major biopharmaceutical companies.

Previous roles included research and management positions with Novartis, Chiron, Rigel and Sugen/Pharmacia.

Chosen for You